PRINCIPLE has been the UK Government's national priority platform trial of COVID-19 treatments, and one of the world's largest currently taking place in an outpatient setting
Read Press ReleaseLTO Network announces that through its collaboration with integrator Sphereon, it will host the world's next generation of eClinical data. Triall will integrate its blockchain APIs with the eClinical solutions of CDS, realizing the world's first end-to-end eClinical platform powered by blockchain.
Read Press ReleaseOliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis.
Read Press ReleasePH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world
Read Press ReleaseGb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines 'Cannabis Business Times' and 'Hemp Grower'
Read Press ReleaseHyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris Systemâ„¢, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read Press ReleaseSwiss Life Sciences Group Plc (SLSG) has identified a need in the fast-growing cannabis and CBD industry to establish a financing and credit facility for companies and brands, especially those in the medical and pharmaceutical sector.
Read Press Release